# Clinical and Translational Science Center

> **NIH NIH UL1** · WEILL MEDICAL COLL OF CORNELL UNIV · 2022 · $10,048,014

## Abstract

Contact PD/PI: IMPERATO-MCGINLEY, JULIANNE L
OVERALL
PROJECT SUMMARY/SUMMARY
The Weill Cornell Medicine Clinical and Translational Science Center’s (CTSC) future strategies are built on the
considerable accomplishments achieved over the last 14 years, providing the translation of research and the
generation of research ideas that pave the way for future innovations despite the effect of the pandemic on the
medical school, with the city in lockdown for over 14 months. The plans for the next five years are devised to
continue to develop the existing infrastructure and its initiatives, to add new ones, to enhance networking, and
to improve diversity, equity, and inclusion. In so doing, we will continue to advance translational science to
improve community health. With our multi-institutional hub of distinguished partners firmly in place, the strategic
plans for the CTSC are geared to rapidly advance translational science discovery by: 1) Enhancing informatics
to increase resource adoption, reduce roadblocks and streamline workflow through training, novel software, and
new collaborations; 2) Improving health inequities, developing strong translational research engagement with
communites, and preparing for health crises, like the COVID-19 pandemic, where the CTSC organized a
vaccination hesitancy program and set up vaccination sites in underserved communities; 3) Continuing to
develop our highly successful clinical and translational education programs through innovative and
entrepreneurial multifaceted initiatives including training in health disparities and a new cross-hub KL2/TL1
collaboration with the Georgetown/Howard CTSA; and 4) Creating Team Science initiatives that promote
inclusion across the CTSC. Innovative didactic opportunities will continue to be offered and expanded, such as
seminars on innovation and entrepreneurship, the newest of which will be a collaborate with eLab on “Unmet
Needs for Stimulating Device Development,” a five-part series which is designed to stimulate device
development. The Pilot Translational and Clinical Studies program will be enhanced to target projects in device
and therapeutics development, precision medicine and research in special populations while promoting
collaborations between the community, community organizations and CTSC Investigators. The CTSC also offers
educative opportunities that reach the broader community such as our Teaching Ethics Through Art program,
while the Special Population Network (SPN) will expand to include community outreach studies and continue
clinical research studies with a focus on the following populations: children, the elderly, ethnic and racial
minorities and those with disabilities. Additionally, the Network Capacity Component will do more outreach to
encourage local investigators to initiate multi-center clinical trials. The CTSC has also been extremely successful
ensuring the availability of biostatisticians from all partners with expertise in diverse disease systems and...

## Key facts

- **NIH application ID:** 10632389
- **Project number:** 2UL1TR002384-06
- **Recipient organization:** WEILL MEDICAL COLL OF CORNELL UNIV
- **Principal Investigator:** JULIANNE L IMPERATO-MCGINLEY
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $10,048,014
- **Award type:** 2
- **Project period:** 2017-09-05 → 2027-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10632389

## Citation

> US National Institutes of Health, RePORTER application 10632389, Clinical and Translational Science Center (2UL1TR002384-06). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10632389. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*